Natl Sci Open
Volume 1, Number 1, 2022
Special Topic: COVID-19: Virus, Immunity and Vaccines
|Number of page(s)||2|
|Section||Life Sciences and Medicine|
|Published online||28 April 2022|
The evolving immunity to SARS-CoV-2
Shanghai Immune Therapy InstituteShanghai Jiao Tong University School of Medicine-affiliated Renji Hospital,
2 Institute of Immunology and Peking University-Tsinghua University Joint Center for Life SciencesTsinghua University, Beijing 100084, China
* Corresponding author (email: email@example.com)
Accepted: 22 April 2022
This article has no abstract.
© The Author(s) 2022. Published by China Science Publishing & Media Ltd. and EDP Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.